Tatsis Ourania

EVP, Chief Reg. &Quality Off. | EVP, Chief Regulatory Officer | SVP, CRO

1 company

Average

Trades Analyzed

12M Win Rate

20.8%

Avg 3M Return

-3.6%

Avg 12M Return

-16.7%

Tatsis Ourania is an EVP, Chief Reg. &Quality Off. at VERTEX PHARMACEUTICALS INC / MA. Recent SEC Form 4 filings include 0 buys and 48 sells.

Estimated insider holdings value: $18.2M based on current market prices.

Holdings by Company

VRTXJan 7, 2026

Current Shares42.3K

Value$18.18M

Net Activity-50,860

Bought: 0Sold: 50.9K

Showing 10 filings (page 3)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 9, 2022	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Chief Reg. &Quality Off.	Sell	1,400	$298.97	$418,556.74	-0.6%	+1.5%	+15.5%
Mar 17, 2022	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Chief Reg. &Quality Off.	Sell	2,833	$250.11	$708,572.06	-2.9%	+1.4%	+18.3%
Feb 25, 2022	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Chief Reg. &Quality Off.	Sell	325	$230.95	$75,058.08	-0.1%	+17.1%	+24.8%
Feb 18, 2022	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Chief Reg. &Quality Off.	Sell	519	$231.00	$119,888.58	-0.2%	+11.3%	+27.9%
Feb 11, 2022	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Chief Reg. &Quality Off.	Sell	290	$235.09	$68,175.14	-0.1%	+3.0%	+27.2%
May 15, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Chief Regulatory Officer	Sell	120	$284.00	$34,080.09	-0.1%	-	-
May 6, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Chief Regulatory Officer	Sale+OE	966	$272.70	$263,431.17	-1.2%	-	-
Feb 25, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	SVP, CRO	Sell	1,296	$233.17	$302,186.72	-1.6%	-	-
Feb 18, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	SVP, CRO	Sell	1,279	$243.62	$311,584.73	-1.6%	-	-
Feb 6, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	SVP, CRO	Sale+OE	967	$239.43	$231,526.89	-1.4%	-	-